Attributes | Values |
---|
rdf:type
| |
Description
| - We synthetised new arylalkanoic acid derivatives bearing methyl(phenethyl)amino groups. These compounds have ability to inhibit the biosynthesis of pro-inflammatory mediator LTB4. Furthermore, we found that 4 of these compounds are more active in the animal model of ulcerative colitis than sulfasalazine, and could therefore be considered as good candidates for ulcerative colitis therapy
- We synthetised new arylalkanoic acid derivatives bearing methyl(phenethyl)amino groups. These compounds have ability to inhibit the biosynthesis of pro-inflammatory mediator LTB4. Furthermore, we found that 4 of these compounds are more active in the animal model of ulcerative colitis than sulfasalazine, and could therefore be considered as good candidates for ulcerative colitis therapy (en)
|
Title
| - Antileukotrienic phenethylamido derivatives of arylalkanoic acids in the treatment of ulcerative colitis
- Antileukotrienic phenethylamido derivatives of arylalkanoic acids in the treatment of ulcerative colitis (en)
|
skos:prefLabel
| - Antileukotrienic phenethylamido derivatives of arylalkanoic acids in the treatment of ulcerative colitis
- Antileukotrienic phenethylamido derivatives of arylalkanoic acids in the treatment of ulcerative colitis (en)
|
skos:notation
| - RIV/61388971:_____/09:00335377!RIV10-AV0-61388971
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| - P(GD310/03/H147), P(LN00B125), S, Z(AV0Z50200510), Z(MSM0021620822)
|
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/61388971:_____/09:00335377
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - N-Phenethyl-2-arylacetamides; Antileukotrienic activity; QSAR (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| - FR - Francouzská republika
|
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| - European Journal of Medicinal Chemistry
|
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...vavai/riv/projekt
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Kuchař, M.
- Kverka, Miloslav
- Macháček, M.
- Jandera, A.
- Junek, R.
- Panajotová, V.
- Šatinský, D.
|
http://linked.open...ain/vavai/riv/wos
| |
http://linked.open...n/vavai/riv/zamer
| |
issn
| |
number of pages
| |
is http://linked.open...avai/riv/vysledek
of | |